Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor

Table 4 Comparison of outcomes of Intra-arterial therapies

Ref.	Publication year	Mode of therapy	Number of patients ablated	Median PFS	Median OS
Paprottka et al[58]	2011	RE	42	1
Dong et al[59]	2011	HACE	123		40 mo
Saxena et al[60]	2010	RE	48		35 mo
Cao et al[61]	2010	RE	58		36 mo
Kennedy et al[62]	2008	RE	148		70 mo
King et al[63]	2008	RE	37		29 mo
Ho et al[64]	2007	HAE/HACE	46	18 mo	42 mo
Ruutiainen et al[65]	2007	HACE	57	36 mo
Strosberg et al[66]	2006	HAE	84		36 mo
Gupta et al[67]	2005	HAE/HACE	123
			74 HAE	22 mo	34 mo
			49 HACE	16 mo	23 mo
Touzios et al[32]	2008	HAE/HACE	100
			51 HAE		25.5 mo
			49 HACE		25.7 mo
Ruszniewski et al[68]	1993	HACE	24	14 mo

¹Mean follow up 16. 2 mo, 95.2% alive. HACE: Hepatic artery chemo-embolization; HAE: Hepatic artery.